... DISEASE2MANAGEMENT OFCERVICAL CANCER 1.2 REMIT OF THE GUIDELINEThis guideline will cover presentation, referral, diagnosis, staging and treatmentofcervical cancer. The management of small cell ... and dependants of patients with cervical cancer. 38MANAGEMENT OFCERVICAL CANCER 312.4 MALODOURMalodour and discharge frequently reect advancing cancer. It is ... support needs ofcancer patients was from small heterogeneous studies and the types of help offered are very varied.238-240 None of the studies was specic to patients with cervicalcancer but...
... cervical cancer, 3-D CT scanning Introduction Uterine cervicalcancer is one of the most com-mon cancers diagnosed in women of reproductive age. Thanks to the progress of the cervicalcancer ... system, the mortality rate of patients with cervical cancer has decreased in Japan over the past twenty years1. However, the number of patients with early invasive cervicalcancer during reproductive ... growth of both patients. Patient 1 received emergent cesarean section at 24 weeks of gestation because of sudden premature rupture of the membrane. Therefore the birth weight of the child of...
... for the treatmentof locally advanced cervical cancer. Results of a trial by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) were presented at the 2000 meeting of the ... with cervicalcancer for whom primary treatment with radiotherapy is being considered: - those with locally advanced cervical cancer, - those with bulky clinical stage IB (>4 cm) cervical cancer, ... with cervicalcancer for whom primary treatment with radiotherapy is being considered: - those with locally advanced cervical cancer, - those with bulky clinical stage IB (>4 cm) cervical cancer, ...
... anoverview. Cancer Detect Prev Suppl1987;1:423-443.9. Kimura Y, Tojima H, Fukase S, et al. Clinicalevaluation of sizofilan as assistant immuno-therapy in treatmentof head and neck cancer. Acta ... quality of life. But the disease ofcancer continues to be the scourge of humanity; being aleading cause of early death, and resistant to therapies aimed at its eradication. Now anotherdimension of ... well-designed trial on PSK therapyin the treatmentof stomach cancer conductedby the Study Group of Immunochemotherapywith PSK for Gastric Cancerof Japan.32 Che-motherapy with PSK was...
... activation of c-Jun N-terminal kinase (JNK) is critical for amplifica-tion of mitochondrial cell death in human cervicalcancer cells. Exposure of HeLa cells to radiation induced loss of mitochondrial ... trans-membrane potential of these cells was determined by assaying the retention of DioC6(3) added during the last 30 min of treatment. Afterremoval of the medium, the amount of retained DioC6(3) ... factor in the development of cancer, as has been demonstrated by enhancedexpression of Bcl-2 in cancer tissues [11]. Recently, ithas been suggested that the anti-apoptotic function of Bcl-2 is...
... men, who account for 60% of lung cancer cases. In women, lung cancer is the second most common cause ofcancer death after breast cancer. Survival rates for lung cancer are very poor. In England, ... radiotherapy should be offered sequential chemoradiotherapy. A 1.8 Treatmentof small-cell lung cancer 1.8.1 Patients with SCLC should be offered an assessment that includes evaluation of the major ... research is needed into whether the use of low-dose CT in early diagnosis of patients at high risk of developing lung cancer has an effect on the mortality of lung cancer. A randomised trial should...
... risk of developmentof cancer. Oral administration of DHEA to mice inhibits spontaneous breast cancer andchemically induced tumors of the lung and colon [7];however, its effect in cervicalcancer ... non-HPV-infected cancer cells. We there-fore believe that alternative therapeutic approachesshould be considered in the treatmentofcervical can-cer. DHEA could be useful in the treatmentof cervical cancer, ... theproliferation ofcervicalcancer cells, but its effect is not mediated byandrogen or estrogen receptor pathways. DHEA could therefore be used asan alternative in the treatmentofcervical cancer. AbbreviationsDHEA,...
... developmentof successful cervical screening programmes 20The strengths of the conventional cervical cytology test 21The implications of different methods of sampling 22The implications of ... the age-related incidence of invasive cancerof the cervix in the country, not on the basis of the percentage distribution by age of clinically detected cases ofcancer in the country. In ... of cancerof the cervix, and a rise in incidence in cancerof the breast, sim-ilar to changes that occurred in North America and Western Europe in the early part of the last century. Many of...
... 16) of the Teaching Hospital of Nanjing Col-lege of TCM explored the anti-tumor mechanism of Qigong therapy in a study of 104 different cancer patients (mainly comprised of esophagus cancer, ... treatment remained intact. Chen YF of Shanghai Institute of TCM studied the effect of EQT on human liver cancer cell line (BEL-7402) and lung cancer cells (SPC-A1). Level of ATP and AFP of ... effect of Qigong EQ on the ConA aglutinating reaction of human lung cancer cells(SPC-A) Chinese Journal of Somatic Science. 2(2): 63-66. 1992 27) Chen YF. Analysis of the effect of EQ of Qigong...
... Strategies for global control ofcervical cancer. International Journal of Cancer, 1995, 60:1-26. 11. Salas I. Methodology for the Re-Organization of the Cervical Cancer Programme in Chile. In ... cvladescu@buc.osf.roRepresentative from European Network of Cervical Cancer: Arbyn, Marc Epidemiologist Scientific Institute of Public Health Coordinator of Flemish Cervical Cancer Screening Programme J.J. Wytsmanstreet, ... the age-related incidence of invasive cancerof the cervix in the country, not on the basis of the percentage distribution by age of clinically detected cases ofcancer in the country. In...
... avariety of human diseases including cancer. Pointmutations, deletions or duplications of mitochondrialD N A a re found in many cancers and theImpact of Molecular Biology on Cancer Treatment: ... valuable inthe treatmentof ER-positive breast cancer. Thefinding that tamoxifen could inhibit the growth of b reast cancer, but at the same time stimulate theg rowth of endometrial cancer in the ... restoration of WT pro t e i n[ 6 7 ], indicates thepotential of this approach. A better description of the systemic nature of the response in wholeImpact of Molecular Biology on Cancer Treatment: ...
... in ovarian cancer. The identification of an FDA approvedanti-VLC agent with a history of clinical use will allow immediate proof -of- principle clinical trials in patientswith ovarian cancer. Published: ... Buckanovich*1,2Address: 1Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, USA, 2Department of Internal Medicine, University of Michigan, Ann Arbor, USA, 3Department of Obstetrics and ... agent with a significant history of clinical usewill allow immediate proof -of- principle cancer therapyclinical trials in humans.AbbreviationsANOVA: Analysis of Variance between Groups; CLL:Chronic...